Taiwan Bio Therapeutics Co., Ltd (TPEX:6892)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
27.00
+2.65 (10.88%)
Apr 29, 2026, 1:36 PM CST
-15.09%
Market Cap 2.28B
Revenue n/a
Net Income n/a
Shares Out 84.61M
EPS n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 189,292
Average Volume 142,866
Open 24.50
Previous Close 24.35
Day's Range 24.50 - 28.30
52-Week Range 23.95 - 36.05
Beta 0.36
RSI 52.24
Earnings Date n/a

About Taiwan Bio Therapeutics

Taiwan Bio Therapeutics Co., Ltd., regenerative medicine company, focuses on the development of new cell medicines. It offers medicines for degenerative diseases, cardiovascular diseases, diabetes complications, and autoimmune diseases. The company was founded in 2014 and is based in Taipei, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2014
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 6892
Full Company Profile

News

There is no news available yet.